SOC Treatment: Clinical Trials

2 terminated, 1 active not recruiting, 1 completed. 2 Phase 3, 1 Not applicable, 1 Phase 1.

By phase and status

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications Pimodivir 600 mg, Placebo, SOC Treatment - Influenza A	Phase 3	Terminated	Janssen Research & Development, LLC	553	2018-01-21	2025-02-04
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection Pimodivir 600 mg, Placebo, SOC Treatment - Influenza A	Phase 3	Terminated	Janssen Research & Development, LLC	334	2018-01-03	2025-02-04
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors mRNA-4157, Pembrolizumab, SoC Treatment - Solid Tumors	Phase 1	Active not recruiting	ModernaTX, Inc.	161	2017-08-14	2026-09-03
Study Evaluating CERAMENT™\|G in Open Diaphyseal Tibial Fractures CERAMENT\|G, SOC treatment - Tibial Fracture	Not applicable	Completed	BONESUPPORT AB	201	2017-02-14	2021-08-10